Responses
Regular and Young Investigator Award Abstracts
Clinical Trials Completed
579 Novel digital image approach of multiplex immunofluorescence based PD-L1 expression enables the stratification of advanced NSCLC patients treated with durvalumab
Compose a Response to This Article
Other responses
No responses have been published for this article.